Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Proteomics|December 8, 2010
In vivo processing of CXCL12α/SDF-1α after intravenous and subcutaneous administration to miceBruno Antonsson, Patricia De Lys, Vincent Dechavanne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Osteopontin is not required for the development of Th1 responses and viral immunityBrian Abel, Stefan Freigang, Martin F Bachmann, et al.
Brain : a Journal of Neurology|April 12, 2003
cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activityMarcin P Mycko, Ruben Papoian, Ursula Boschert, et al.
Scientific Reports|May 18, 2023
Revealing the immune cell subtype reconstitution profile in patients from the CLARITY study using deconvolution algorithms after cladribine tablets treatmentIrina Kalatskaya, Gavin Giovannoni, Thomas Leist, et al.
Clinical Neurology and Neurosurgery|June 5, 2004
Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosisMarcin P Mycko, Ruben Papoian, Ursula Boschert, et al.
Neurodegenerative Disease Management|December 22, 2022
A plain language summary of the impact of vaccines against flu and chickenpox in people with multiple sclerosis treated with cladribine tabletsKlaus Schmierer, Heinz Wiendl, Celia Oreja-Guevara, et al.
Glia|February 23, 2008
GlialCAM, an immunoglobulin-like cell adhesion molecule is expressed in glial cells of the central nervous systemLinda Favre-Kontula, Alexandre Rolland, Lilia Bernasconi, et al.
Brain Plasticity (Amsterdam, Netherlands)|December 7, 2020
Bruton's Tyrosine Kinase Inhibition Promotes Myelin RepairElodie Martin, Marie-Stéphane Aigrot, Roland Grenningloh, et al.
Cells|December 24, 2021
Immunomodulatory Effects Associated with Cladribine TreatmentNicolás Fissolo, Laura Calvo-Barreiro, Herena Eixarch, et al.
Journal of Clinical Pharmacology|April 10, 2015
Effect of ceralifimod (ONO-4641) on lymphocytes and cardiac function: Randomized, double-blind, placebo-controlled trial with an open-label fingolimod armSonja Krösser, Peter Wolna, Tanya Z Fischer, et al.
Pageof 3